Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population

BackgroundStatin therapy in multimorbid older individuals with polypharmacy is controversial, particularly in primary prevention of cardiovascular disease. Thereby, physicians must weigh potential benefits against potential side effects, drug-drug interactions, and limited life expectancy.AimTo asse...

Full description

Bibliographic Details
Main Authors: Luise Adam, Oliver Baretella, Martin Feller, Manuel Raphael Blum, Dimitrios David Papazoglou, Benoit Boland, Drahomir Aujesky, Stéphanie Baggio, Nicolas Rodondi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
polypharmacy
multimorbidity
cardiovascular prevention
statin
-guideline adherence
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1236547/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1236547/full

Similar Items